Luminex Teams With Merck For Alzheimer’s Companion Diagnostic
This article was originally published in The Gray Sheet
Executive Summary
The assay will be used to support patient selection as part of Merck’s ongoing clinical trial program for the MK-8931 Alzheimer’s disease drug candidate.